Previous 10 | Next 10 |
2024-02-12 10:32:46 ET More on Coca-Cola Stocks To Watch: Spotlight On Coca-Cola, Coinbase, Shopify And Cisco Coca-Cola: IRS Claim - A Matter Of Risk And Consequence Coca-Cola: A Dominant Force With High Upside Earnings week ahead: Coca-Cola, Cisco, Shopify, ...
2024-02-12 08:45:00 ET Biotech giant Eli Lilly (NYSE: LLY) is firing on all cylinders. The company has scorched the broader market over the past year thanks to its rapidly growing revenue and important clinical and regulatory progress. However, the No. 1 reason Eli Lilly has been pe...
2024-02-12 08:41:44 ET More on Novo Nordisk Novo Nordisk A/S (NVO) Q4 2023 Earnings Call Transcript Biotech And Pharma Diversification Pays Off Novo Nordisk: Outlook For Weight Loss Drugs In 2024 Booming weight-loss drug market to lift “pick-and-shovel...
2024-02-12 05:03:00 ET You may not expect a pharmaceutical stock to mimic the behavior of the latest hot growth stock and soar in the triple digits over 12 months. But Eli Lilly (NYSE: LLY) did it, climbing nearly 117% over the past year. This wasn't just a random happening, but ins...
2024-02-11 12:00:03 ET More on Eli Lilly, Novo Nordisk, etc. Will Eli Lilly and Company Become A Trillion-Dollar Baby? Eli Lilly and Company: Even 'Miracle Drugs' Can't Keep Stock Rising (Downgrade) Eli Lilly and Co (LLY) Q4 2023 Earnings Conference Call Transcript ...
2024-02-11 08:19:38 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The D...
2024-02-11 03:24:52 ET Summary NVIDIA and Meta Platforms have surged, while Apple and Tesla have struggled, shaking up the Magnificent Seven. The Mag 7's weight in the S&P 500 has reached 29% but its earnings share is at a record high, too. The MAGS ETF has performed well,...
2024-02-11 01:25:00 ET Summary I-Mab Hangzhou will acquire rights to I-Mab’s drug assets in Greater China for $80 M. Anbogen Therapeutics raised $12.5M in a Series A funding round. to advance its two lead drug candidates. Bayer signed a non-binding Letter of Intent to m...
2024-02-10 11:30:00 ET In science and in life, there's a special prestige that comes with being the first person or group to crack a previously intractable problem by using a cunning approach. Believe it or not, bragging rights matter to massive pharma players like Eli Lilly (NYSE: LL...
2024-02-10 06:49:00 ET Arguably the most important quality for any stock is whether or not it beats the market. If it doesn't, you'd be better off putting your money in an index fund. Three Motley Fool contributors think healthcare stocks Eli Lilly (NYSE: LLY) , Novo Nordisk ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-29 09:20:00 ET While the market for anti-obesity medicines is characterized today by a fight between Novo Nordisk 's (NYSE: NVO) drug Wegovy and Eli Lilly 's (NYSE: LLY) drug Zepbound, that won't always be the case. Over the coming years, the competitive dynamics of ...
2024-07-29 07:30:00 ET When a major player announces good news in a lucrative market like weight loss drugs, it's often enough to drive shares of competitors down based on the assumption that they will have struggles ahead. That's just what happened after an announcement by Roche Hold...
2024-07-27 07:15:00 ET According to some research, bull markets tend to last an average of 2.6 years. The one we are currently experiencing has been going on for almost two years -- maybe it will soon end, maybe it won't. Equities that can perform well throughout bull runs might be good to ...